PUT - SPRINTER OPEN END - MERCK & CO. Share Price

Certificat

DE000VM71VY3

Real-time Boerse Frankfurt Warrants 01:43:13 05/06/2024 pm IST
0.73 EUR -8.75% Intraday chart for PUT - SPRINTER OPEN END - MERCK & CO.
Current month-27.27%
1 month-6.98%
Date Price Change
05/24/05 0.73 -8.75%
04/24/04 0.8 -4.76%
03/24/03 0.84 -23.64%
31/24/31 1.1 +25.00%
30/24/30 0.88 -15.38%

Real-time Boerse Frankfurt Warrants

Last update June 05, 2024 at 01:43 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM71VY
ISINDE000VM71VY3
Date issued 05/01/2024
Strike 136.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.86
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.86
Lowest since issue 0.33
Spread 0.08
Spread %9.88%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128.7 USD
Average target price
142.7 USD
Spread / Average Target
+10.86%
Consensus